Back to Search
Start Over
Nucleoside-Sparing Regimens with Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue
- Publication Year :
- 2016
-
Abstract
- Author(s): Karris, Maile Y; Jain, Sonia; Bowman, Vi Q; Rieg, Gunter; Goicoechea, Miguel; Dube, Michael P; Kerkar, Shubha; Kemper, Carol; Diamond, Catherine; Sun, Xiaoying; Daar, Eric S; Haubrich, Richard H; Morris, Sheldon; California Collaborative Treatment Group (CCTG) 589 Study Team
- Subjects :
- 0301 basic medicine
Adult
Cyclopropanes
Male
Tenofovir
Anti-HIV Agents
media_common.quotation_subject
Treatment outcome
Atazanavir Sulfate
HIV Infections
Article
Lopinavir
Raltegravir Potassium
03 medical and health sciences
0302 clinical medicine
Surveys and Questionnaires
medicine
Emtricitabine
Humans
Pharmacology (medical)
Protease inhibitor (pharmacology)
030212 general & internal medicine
Theology
media_common
Ritonavir
Dose-Response Relationship, Drug
Art
HIV Protease Inhibitors
Middle Aged
Raltegravir
030112 virology
Benzoxazines
Infectious Diseases
Treatment Outcome
Alkynes
RNA, Viral
Drug Therapy, Combination
Female
medicine.drug
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....898fbc41787fa1dd76d4a4d7bda5b41c